"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to ZLDPF. [ FAQ on what and how to ask] For non-ZLDPF questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Adam Sinding Steensberg M.D.
Headquarter: Sydmarken 11, Søborg, Denmark, 2860
Industry: Biotechnology, Investment Track: CNS autoimmune therapy, Employees: 481
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.
My Watchlist
